Concepedia
Statistics
Publications
28
Citations
939
H-Index
18
Active since
2004
Affiliations
Central South University(Current)
Third Xiangya Hospital
Capital Medical University
Sun Yat-sen University
The University of Texas Southwestern Medical Center
Jing Tan is an author at Central South University specializing in medicine, molecular oncology, and oncology.
Publications per year
2004–2024
Impact of the Metalloproteinase-9/Tissue Inhibitor of Metalloproteinase-1 System on Large Arterial Stiffness in Patients with Essential Hypertension
Jing Tan, Qi Hua, Xiurong Xing et al. · Hypertension Research · 2007 · 93 citations · Full text
Medicine, Cardiology, Internal Medicine +15
The prognostic role of preoperative serum albumin/globulin ratio in patients with bladder urothelial carcinoma undergoing radical cystectomy
Jianye Liu, Yingbo Dai, Fangjian Zhou et al. · Urologic Oncology Seminars and Original Investigations · 2016 · 84 citations
Medicine, Surgery, Urology +12
Clinical Implications of Elevated Serum Interleukin‐6, Soluble CD40 Ligand, Metalloproteinase‐9, and Tissue Inhibitor of Metalloproteinase‐1 in Patients with Acute ST‐segment Elevation Myocardial Infarction
Jing Tan, Qi Hua, Jing Gao et al. · Clinical Cardiology · 2008 · 82 citations · Full text
Medicine, Cardiology, Clinical Cardiology +16
Simultaneously expressed miR-424 and miR-381 synergistically suppress the proliferation and survival of renal cancer cells—Cdc2 activity is up-regulated by targeting WEE1
Binghai Chen, Lujing Duan, Guangming Yin et al. · Clinics · 2013 · 66 citations · Full text
Medicine, Cell Biology, Oncology +17
miR-381, a novel intrinsic WEE1 inhibitor, sensitizes renal cancer cells to 5-FU by up-regulation of Cdc2 activities in 786-O
Binghai Chen, Lujing Duan, Guangming Yin et al. · Journal of Chemotherapy · 2013 · 51 citations
Medicine, Oncology, Pharmacology +17
1–5 of 28